AbCellera Biologics Inc. ABCL Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s other non-current liabilities?
- AbCellera Biologics Inc. (ABCL) reported other non-current liabilities of $11.32M in Q1 2026.
- How has AbCellera Biologics Inc.'s other non-current liabilities changed year-over-year?
- AbCellera Biologics Inc.'s other non-current liabilities increased by 597.1% year-over-year, from $1.62M to $11.32M.
- What is the long-term trend for AbCellera Biologics Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s other non-current liabilities has grown at a 16.0% compound annual growth rate (CAGR), from $6.62M to $13.88M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.